Moderna has been testing an mRNA candidate for influenza viruses like the H5 and H7 strains that are seen as pandemic threats ...

The funding, which follows the $176 million the government awarded Moderna in June 2024, aims to get mRNA vaccines ready ...

Earlier this month, Moderna announced business updates and progress across its pipeline. Moderna says it enters 2025 with a ...

The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.

Moderna received a $590 million award from the U.S. government to speed development of a vaccine that could be used to fight bird flu.

US health officials announced Friday they were awarding $590 million to Moderna to develop mRNA vaccines against influenza, ...

In 2023, Moderna initiated a study on a “pandemic influenza vaccine” to protect against H5 and H7 avian influenza viruses. In July, the company received $176 million from HHS toward its ...

There have been 67 confirmed human bird flu cases in the U.S. since April 2024. Moderna has been awarded approximately $590 million from the federal government to help speed up the development of ...

Moderna's influenza vaccine candidate uses conventional mRNA technology that was leveraged successfully during the COVID-19 response, resulting in one of the first two FDA-authorized - and ...

The public health risk remains low, but bird flu variants have proven to be unpredictable, which is why the virus is a top ...